gemcitabina

No posts available.

Estudio dirigido por Mayo Clinic descubre que combinación de 2 fármacos lentifica el avance del cáncer de páncreas

SCOTTSDALE, Arizona — 6 de abril de 2012. La combinación del novedoso fármaco TH-302 con el medicamento estándar gemcitabina mostró las primeras señales de que [...]

By • April 6, 2012

Science Saturday: Mayo Clinic study reveals aging speeds genomic mutations in brain

Somatic mutations naturally occur in cells throughout human development and during aging. However, it has yet to be determined whether the frequency of somatic mutations [...]

By Colette Gallagher • October 1, 2022

Mayo Clinic installs 1st Quadra PET/CT scanner in North America

System will enable Mayo Clinic to achieve tenfold improvement in imaging for patients

ROCHESTER, Minn. — Mayo Clinic has installed a new PET/CT scanner that [...]

By Ethan Grove • September 30, 2022

Natalie Caine named chief administrative officer at Mayo Clinic in Rochester

ROCHESTER, Minn. — Mayo Clinic has named Natalie Caine chief administrative officer for Mayo Clinic in Rochester. She succeeds Mary Jo Williamson, who rotated [...]

By Kristy Jacobson • September 30, 2022

Consumer Health: What do you know about the types of thyroid cancer?

September is Thyroid Cancer Awareness Month, which makes this a good time to learn about the different types of thyroid cancer.

Nearly 44,000 new [...]

By Laurel Kelly • September 30, 2022